한국지질동맥경화학회 학술대회

TBD

TBD

TBD

Interplay between molecular and environmental factors in the new era of precision medicine

Human microbiome and the path to cardiometabolic health

Iron overload, autophagy dysfunction, and ferroptosis: mechanistic insights into cardiometabolic disease

Epidemiologic evidence on Lp(a) and ASCVD in Asian populations

The inverse link between Lp(a) and metabolic risk: signal or noise?

Lp(a) testing today: mind the method, mind the unit

From nanoparticles to biocides: how toxic chemicals alter lipid homeostasis and accelerate atherosclerotic events

Immune modulation of lipid metabolism promotes BAT whitening under thermoneutral conditions

Role of MCU in human platelet aggregation

Coronary atherosclerosis and cardiovascular risk prediction through AI-assisted stress echocardiography: insights from the PROTEUS RCT trial

AI-enhanced ECG for acute myocardial infarction detection and cardiovascular risk stratification

Artificial intelligence-based coronary artery disease screening versus usual care for patients with suspected coronary artery disease: AI-Gatekeeper randomized controlled trial

CVD risk prediction in low-risk population

CVD risk prediction in older persons

CVD risk prediction in diabetes and high-risk patients

Deep dive into PCSK9: the master regulator of LDL metabolism and inflammation

siRNA-based lipid therapies: a revolution in cholesterol management

Novel strategies for familial hypercholesterolemia management beyond statins

Prediction of ASCVD using the TyG index: insights from the multinational PURE registry

Prediction of ASCVD using the TyG index: evidence from Korean data

Prediction of coronary artery calcification progression using the TyG index

Beyond statins: advances in FH management

Early detection of FH: role of genetic screening and cascade testing

Cardiovascular risk in FH: how early is early enough for intervention?

LDL-C targets for patients with diabetes across major guidelines

Pro: all patients with diabetes should be treated to LDL-C <55 mg/dL?

Cons: LDL-C targets should be personalized in diabetic patients?

Mechanisms linking socioeconomic status and cardiovascular risk

Epidemiologic evidence on socioeconomic status and cardiovascular outcomes

New models for CVD risk assessment: incorporating socioeconomic data